MUC13 and hepatocellular carcinoma: Particularly noteworthy is that previous research has shown that MUC13, through its interaction with GCNT3, activates the GSK3β/β-catenin signaling pathway, promoting hepatocellular carcinoma progression 31, a key focus of this study.